Clinical Trials Browser

Phase 2 × Withdrawn × balstilimab × Clear all

NCT05033132 2024-03-28

A Phase II Study of Balstilimab Independently or in Combination With Zalifrelimab in Advanced Cervical Cancer

Phase 2 Withdrawn

Uterine Cervical Neoplasms

NCT05561491 2023-06-22

A Study of ONCOS-102 in Combination With Other Novel Immune-therapies in Advanced Treatment-resistant Melanoma Patients

Phase 2 Withdrawn

Melanoma, Neoplasm Metastasis

NCT04607200 2022-01-11

AGEN2034 & AGEN1884 in Patients With Recurrent, Inoperable Angiosarcoma

Phase 2 Withdrawn

Hemangiosarcoma